Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions

Determination of Prostate Volume

(2018) Adam Bezinque et al.   ACADEMIC RADIOLOGY

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions

(2018) Anwar R. Padhani et al.   EUROPEAN UROLOGY

Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?

(2018) Valeria Panebianco et al.   EUROPEAN UROLOGY

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

(2018) Veeru Kasivisvanathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings

(2018) Marc A. Bjurlin et al.   UROLOGY

A Magnetic Resonance Imaging–Based Prediction Model for Prostate Biopsy Risk Stratification

(2018) Sherif Mehralivand et al.   JAMA Oncology

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study

(2018) Marloes van der Leest et al.   EUROPEAN UROLOGY

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study

(2018) Olivier Rouvière et al.   LANCET ONCOLOGY

Complications After Systematic, Random, and Image-guided Prostate Biopsy

(2017) Marco Borghesi et al.   EUROPEAN UROLOGY

What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel

(2017) Paul C. Moldovan et al.   EUROPEAN UROLOGY

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer—Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies

(2017) Jan Philipp Radtke et al.   EUROPEAN UROLOGY

The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer Prediction

(2017) Florian A. Distler et al.   JOURNAL OF UROLOGY

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool

(2017) Su-Min Lee et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone

(2017) Xiang-ke Niu et al.   BMC MEDICAL IMAGING

Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population

(2016) Dong Fang et al.   ANNALS OF SURGICAL ONCOLOGY

The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting

(2016) Nienke L. Hansen et al.   BJU INTERNATIONAL

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients

(2016) Satoshi Washino et al.   BJU INTERNATIONAL

Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans

(2016) Arnout R. Alberts et al.   EUROPEAN UROLOGY

Is the Ellipsoid Formula the New Standard for 3-Tesla MRI Prostate Volume Calculation without Endorectal Coil?

(2016) Matthias Haas et al.   UROLOGIA INTERNATIONALIS

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer

(2014) Donna P. Ankerst et al.   UROLOGY

Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing

(2013) Marc A. Bjurlin et al.   JOURNAL OF UROLOGY

Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol

(2011) Idir Ouzaid et al.   WORLD JOURNAL OF UROLOGY

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY

A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

(2009) Monique J. Roobol et al.   EUROPEAN UROLOGY

A graphical device to represent the outcomes of a logistic regression analysis

(2008) Ries Kranse et al.   PROSTATE